Cargando…

HIV prevalence in the Israeli tuberculosis cohort, 1999–2011

BACKGROUND: Tuberculosis (TB) patients who are co-infected with HIV are at greater risk of mortality. Nevertheless, not all countries achieved sustainable and TB and HIV collaboration to describe the burden of both diseases at a national scale. This study aims to describe HIV prevalence among TB-pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Zohar, Mor, Moshe, Lidji, Daniel, Chemtob, Noa, Cedar, Itamar, Grotto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221682/
https://www.ncbi.nlm.nih.gov/pubmed/25335562
http://dx.doi.org/10.1186/1471-2458-14-1090
_version_ 1782342914203975680
author Zohar, Mor
Moshe, Lidji
Daniel, Chemtob
Noa, Cedar
Itamar, Grotto
author_facet Zohar, Mor
Moshe, Lidji
Daniel, Chemtob
Noa, Cedar
Itamar, Grotto
author_sort Zohar, Mor
collection PubMed
description BACKGROUND: Tuberculosis (TB) patients who are co-infected with HIV are at greater risk of mortality. Nevertheless, not all countries achieved sustainable and TB and HIV collaboration to describe the burden of both diseases at a national scale. This study aims to describe HIV prevalence among TB-patients in Israel and identify variable associated with TB/HIV co-infection. METHODS: This retrospective study was conducted by cross-matching the National HIV and TB Registries to describe TB/HIV epidemiology during the last 13-years and define variables predicting TB/HIV co-infection. RESULTS: Between 1999 and 2011, 5,502 TB-patients were reported: 779 (14.2%) were Israeli-born and 4,723 (85.8%) non-Israeli born. Of all TB patients, 254 (4.6%) were HIV-infected. The trend of HIV/TB co-infection among non-Israeli born has generally decreased since 2003 (trend analysis p < 0.001). TB/HIV co-infected patients were mostly males, their TB diagnosis had been performed relatively in shorter time following their arrival in Israel, more likely to be in the 35–44 and 25–34 age groups, non-Israeli born (mostly Africa born), more likely to be culture positive, have multi-drug resistant strains, had worse treatment outcomes and more likely to die treatment than HIV-negative tuberculosis patient. In a multivariate analysis, short time after arrival in Israel, older age, being born in Ethiopia, having positive sputum, positive culture and multi-drug resistant TB predicted TB/HIV co-infection. TB/HIV co-infected patients with extra-pulmonary TB had a higher proportion of infection in lymphatic, miliary and abdominal sites than those with extra-pulmonary TB who were HIV-negative. CONCLUSIONS: Most TB/HIV co-infected patients were migrants originating in high-burden countries. Despite the moderate 4.6% TB/HIV co-infection rate in Israel, these patients had worse treatment outcomes and higher mortality rates. This study illustrates the importance of integrating TB with HIV in surveillance and treatment components, which should be employed in other countries, as it has a positive impact on disease control.
format Online
Article
Text
id pubmed-4221682
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42216822014-11-07 HIV prevalence in the Israeli tuberculosis cohort, 1999–2011 Zohar, Mor Moshe, Lidji Daniel, Chemtob Noa, Cedar Itamar, Grotto BMC Public Health Research Article BACKGROUND: Tuberculosis (TB) patients who are co-infected with HIV are at greater risk of mortality. Nevertheless, not all countries achieved sustainable and TB and HIV collaboration to describe the burden of both diseases at a national scale. This study aims to describe HIV prevalence among TB-patients in Israel and identify variable associated with TB/HIV co-infection. METHODS: This retrospective study was conducted by cross-matching the National HIV and TB Registries to describe TB/HIV epidemiology during the last 13-years and define variables predicting TB/HIV co-infection. RESULTS: Between 1999 and 2011, 5,502 TB-patients were reported: 779 (14.2%) were Israeli-born and 4,723 (85.8%) non-Israeli born. Of all TB patients, 254 (4.6%) were HIV-infected. The trend of HIV/TB co-infection among non-Israeli born has generally decreased since 2003 (trend analysis p < 0.001). TB/HIV co-infected patients were mostly males, their TB diagnosis had been performed relatively in shorter time following their arrival in Israel, more likely to be in the 35–44 and 25–34 age groups, non-Israeli born (mostly Africa born), more likely to be culture positive, have multi-drug resistant strains, had worse treatment outcomes and more likely to die treatment than HIV-negative tuberculosis patient. In a multivariate analysis, short time after arrival in Israel, older age, being born in Ethiopia, having positive sputum, positive culture and multi-drug resistant TB predicted TB/HIV co-infection. TB/HIV co-infected patients with extra-pulmonary TB had a higher proportion of infection in lymphatic, miliary and abdominal sites than those with extra-pulmonary TB who were HIV-negative. CONCLUSIONS: Most TB/HIV co-infected patients were migrants originating in high-burden countries. Despite the moderate 4.6% TB/HIV co-infection rate in Israel, these patients had worse treatment outcomes and higher mortality rates. This study illustrates the importance of integrating TB with HIV in surveillance and treatment components, which should be employed in other countries, as it has a positive impact on disease control. BioMed Central 2014-10-21 /pmc/articles/PMC4221682/ /pubmed/25335562 http://dx.doi.org/10.1186/1471-2458-14-1090 Text en © Zohar et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Zohar, Mor
Moshe, Lidji
Daniel, Chemtob
Noa, Cedar
Itamar, Grotto
HIV prevalence in the Israeli tuberculosis cohort, 1999–2011
title HIV prevalence in the Israeli tuberculosis cohort, 1999–2011
title_full HIV prevalence in the Israeli tuberculosis cohort, 1999–2011
title_fullStr HIV prevalence in the Israeli tuberculosis cohort, 1999–2011
title_full_unstemmed HIV prevalence in the Israeli tuberculosis cohort, 1999–2011
title_short HIV prevalence in the Israeli tuberculosis cohort, 1999–2011
title_sort hiv prevalence in the israeli tuberculosis cohort, 1999–2011
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221682/
https://www.ncbi.nlm.nih.gov/pubmed/25335562
http://dx.doi.org/10.1186/1471-2458-14-1090
work_keys_str_mv AT zoharmor hivprevalenceintheisraelituberculosiscohort19992011
AT moshelidji hivprevalenceintheisraelituberculosiscohort19992011
AT danielchemtob hivprevalenceintheisraelituberculosiscohort19992011
AT noacedar hivprevalenceintheisraelituberculosiscohort19992011
AT itamargrotto hivprevalenceintheisraelituberculosiscohort19992011